Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Conivaptan | hsa00030 | Pentose phosphate pathway | 1.94E-03 | 3 | P60891, P52209, P37837 | PRPS1, PGD, TALDO1 | More | | Conivaptan | hsa00052 | Galactose metabolism | 6.39E-04 | 2 | P06280, O43451 | GLA, MGAM | More | | Conivaptan | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Conivaptan | hsa00061 | Fatty acid biosynthesis | 4.83E-02 | 1 | P33121 | ACSL1 | More | | Conivaptan | hsa00071 | Fatty acid degradation | 1.81E-03 | 6 | P11310, O75521, P00325, P11766, P28332, P33121 | ACADM, ECI2, ADH1B, ADH5, ADH6, ACSL1 | More | | Conivaptan | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | | Conivaptan | hsa00190 | Oxidative phosphorylation | 2.80E-06 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Conivaptan | hsa00220 | Arginine biosynthesis | 4.40E-02 | 1 | P15104 | GLUL | More | | Conivaptan | hsa00230 | Purine metabolism | 1.56E-02 | 3 | Q7LG56, P51828, Q9Y227 | RRM2B, ADCY7, ENTPD4 | More | | Conivaptan | hsa00240 | Pyrimidine metabolism | 1.45E-02 | 2 | Q7LG56, Q9Y227 | RRM2B, ENTPD4 | More | | Conivaptan | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Conivaptan | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Conivaptan | hsa00500 | Starch and sucrose metabolism | 9.97E-06 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Conivaptan | hsa00512 | Mucin type O-glycan biosynthesis | 3.19E-03 | 3 | O95395, Q8N4A0, Q9NY28 | GCNT3, GALNT4, GALNT8 | More | | Conivaptan | hsa00513 | Various types of N-glycan biosynthesis | 4.83E-02 | 1 | Q9NR34 | MAN1C1 | More | | Conivaptan | hsa00520 | Amino sugar and nucleotide sugar metabolism | 1.59E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Conivaptan | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Conivaptan | hsa00561 | Glycerolipid metabolism | 4.33E-04 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Conivaptan | hsa00564 | Glycerophospholipid metabolism | 2.80E-02 | 3 | P23743, O14494, Q3LIE5 | DGKA, PLPP1, ADPRM | More | | Conivaptan | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Conivaptan | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Conivaptan | hsa00591 | Linoleic acid metabolism | 1.95E-03 | 1 | P11712 | CYP2C9 | More | | Conivaptan | hsa00600 | Sphingolipid metabolism | 3.70E-03 | 5 | P07602, Q9BX95, Q13510, O14494, P06280 | PSAP, SGPP1, ASAH1, PLPP1, GLA | More | | Conivaptan | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Conivaptan | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 7.10E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Conivaptan | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.36E-07 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Conivaptan | hsa00670 | One carbon pool by folate | 1.33E-02 | 2 | P04818, Q99707 | TYMS, MTR | More | | Conivaptan | hsa00730 | Thiamine metabolism | 1.84E-06 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Conivaptan | hsa00750 | Vitamin B6 metabolism | 3.56E-02 | 1 | O00764 | PDXK | More | | Conivaptan | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Conivaptan | hsa00830 | Retinol metabolism | 1.54E-05 | 5 | P00325, P11766, Q9BPW9, O75911, P11712 | ADH1B, ADH5, DHRS9, DHRS3, CYP2C9 | More | | Conivaptan | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Conivaptan | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.24E-03 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | | Conivaptan | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Conivaptan | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Conivaptan | hsa00983 | Drug metabolism - other enzymes | 8.82E-04 | 4 | P20839, P32320, P05164, Q16772 | IMPDH1, CDA, MPO, GSTA3 | More | | Conivaptan | hsa01100 | Metabolic pathways | 6.34E-04 | 43 | Q9NR34, Q9Y234, P05089, O14521, Q99707, P11310, P27707, P32320, Q3LIE5, P22748, P55809, P06280, Q16875, O43286, O43451, P11712, P05186, P24666, P23743, O14494, Q02252, O60701, O14772, P28332, Q9HCC0, P33121, P04406, Q9NY28, P57054, Q9UNP4, Q9BX95, Q53FZ2, P09960, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q13488, Q16718, Q02809 | MAN1C1, LIPT1, ARG1, SDHD, MTR, ACADM, DCK, CDA, ADPRM, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, CYP2C9, ALPL, ACP1, DGKA, PLPP1, ALDH6A1, UGDH, FPGT, ADH6, MCCC2, ACSL1, GAPDH, GALNT8, PIGP, ST3GAL5, SGPP1, ACSM3, LTA4H, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, TCIRG1, NDUFA5, PLOD1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.705 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.814 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q99707 | MTR | Methionine synthase | 0.725 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P11310 | ACADM | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 0.909 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P27707 | DCK | Deoxycytidine kinase | 0.85 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q3LIE5 | ADPRM | Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase | -0.736 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P06280 | GLA | Alpha-galactosidase A | -0.785 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P11712 | CYP2C9 | Cytochrome P450 2C9 | 0.761 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | 0.704 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P23743 | DGKA | Diacylglycerol kinase alpha | -0.77 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | O14494 | PLPP1 | Phospholipid phosphatase 1 | 0.756 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q02252 | ALDH6A1 | Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial | 0.803 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | O60701 | UGDH | UDP-glucose 6-dehydrogenase | 0.858 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | O14772 | FPGT | Fucose-1-phosphate guanylyltransferase | 0.897 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P28332 | ADH6 | Alcohol dehydrogenase 6 | 0.821 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | -0.757 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | -0.777 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q9NY28 | GALNT8 | Probable polypeptide N-acetylgalactosaminyltransferase 8 | 0.876 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q53FZ2 | ACSM3 | Acyl-coenzyme A synthetase ACSM3, mitochondrial | 0.753 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | P09960 | LTA4H | Leukotriene A-4 hydrolase | -0.874 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | 0.771 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.79 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.755 | Q9UNH5 | CDC14A | Dual specificity protein phosphatase CDC14A | Q02809 | PLOD1 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | -0.724 |
| Conivaptan | hsa01210 | 2-Oxocarboxylic acid metabolism | 2.50E-05 | 1 | P50213 | IDH3A | More | | Conivaptan | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Conivaptan | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 3.18E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Conivaptan | hsa01522 | Endocrine resistance | 4.22E-03 | 5 | P22694, P04049, P08069, P10415, Q13323 | PRKACB, RAF1, IGF1R, BCL2, BIK | More | | Conivaptan | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Conivaptan | hsa01524 | Platinum drug resistance | 6.89E-04 | 7 | P10415, Q13489, P98170, P78417, P23025, P43246, P31751 | BCL2, BIRC3, BIRC4, GSTO1, XPA, MSH2, AKT2 | More | | Conivaptan | hsa02010 | ABC transporters | 1.66E-04 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Conivaptan | hsa03008 | Ribosome biogenesis in eukaryotes | 1.37E-03 | 4 | O14980, O60832, P78345, Q9BVP2 | XPO1, DKC1, RPP38, GNL3 | More | | Conivaptan | hsa03010 | Ribosome | 7.34E-03 | 6 | P62753, P62829, P62888, P61927, P61513, P36578 | RPS6, RPL23, RPL30, RPL37, RPL37A, RPL4 | More | | Conivaptan | hsa03013 | RNA transport | 1.21E-07 | 19 | O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, EIF4B, TACC3 | More | | Conivaptan | hsa03020 | RNA polymerase | 2.06E-03 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Conivaptan | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Conivaptan | hsa03040 | Spliceosome | 9.46E-12 | 19 | Q14562, O43143, O60508, P17844, P08579, Q15427, P26368, P51991, P38159, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, SF3B4, U2AF2, HNRPA3, RBMX, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.775 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.871 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.809 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.76 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.787 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15427 | SF3B4 | Splicing factor 3B subunit 4 | 0.71 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.702 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P38159 | RBMX | RNA-binding motif protein, X chromosome | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.784 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.879 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.712 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.827 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.806 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.822 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.783 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.703 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.943 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.876 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Conivaptan | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Conivaptan | hsa03060 | Protein export | 1.20E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Conivaptan | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Conivaptan | hsa04010 | MAPK signaling pathway | 1.69E-03 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Conivaptan | hsa04012 | ErbB signaling pathway | 6.03E-04 | 7 | P21860, P16333, Q13557, P19174, O14944, P01106, P04049 | ERBB3, NCK1, CAMK2D, PLCG1, EREG, MYC, RAF1 | More | | Conivaptan | hsa04014 | Ras signaling pathway | 2.30E-06 | 14 | P04049, P31751, P42338, P20827, Q9NRA1, P49767, P08069, Q13009, Q7LDG7, P0DP23, P62873, P63218, P50151, P19174 | RAF1, AKT2, PIK3CB, EFNA1, PDGFC, VEGFC, IGF1R, TIAM1, RASGRP2, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.813 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P20827 | EFNA1 | Ephrin-A1 | -0.763 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.776 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.71 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.838 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 |
| Conivaptan | hsa04015 | Rap1 signaling pathway | 1.66E-05 | 15 | P04049, P20827, P49767, P08069, Q96FS4, P11215, P25116, Q8TEU7, Q13009, Q7LDG7, P42338, P31751, P0DP23, P08514, P19174 | RAF1, EFNA1, VEGFC, IGF1R, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, RASGRP2, PIK3CB, AKT2, CALM1, ITGA2B, PLCG1 | More | | Conivaptan | hsa04020 | Calcium signaling pathway | 6.50E-04 | 6 | Q96DU7, P45880, Q13557, P21860, P51828, P23634 | ITPKC, VDAC2, CAMK2D, ERBB3, ADCY7, ATP2B4 | More | | Conivaptan | hsa04022 | cGMP-PKG signaling pathway | 2.77E-05 | 10 | P24844, P04049, Q99941, P23634, Q8WYR1, P31751, P51828, P45880, Q15746, P0DP23 | MYL9, RAF1, CREBL1, ATP2B4, PIK3R5, AKT2, ADCY7, VDAC2, MYLK, CALM1 | More | | Conivaptan | hsa04024 | cAMP signaling pathway | 2.44E-05 | 6 | P31751, P0DP23, P04049, P48058, P25116, P24844 | AKT2, CALM1, RAF1, GRIA4, F2R, MYL9 | More | | Conivaptan | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Conivaptan | hsa04062 | Chemokine signaling pathway | 2.94E-07 | 19 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q7LDG7, Q13009, P14598, P42224, P04049, P25963, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, NCF1, STAT1, RAF1, NFKBIA, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.782 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.767 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q13547 | HDAC1 | Histone deacetylase 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.864 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q13547 | HDAC1 | Histone deacetylase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.815 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.746 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.771 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.785 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Conivaptan | hsa04064 | NF-kappa B signaling pathway | 3.56E-09 | 21 | P10415, Q13489, O00463, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.832 | P06737 | PYGL | Glycogen phosphorylase, liver form | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.924 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.932 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.783 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.967 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.751 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q8WV28 | BLNK | B-cell linker protein | -0.706 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q8WV28 | BLNK | B-cell linker protein | -0.704 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q8WV28 | BLNK | B-cell linker protein | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | P06737 | PYGL | Glycogen phosphorylase, liver form | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.822 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09341 | CXCL1 | Growth-regulated alpha protein | 0.74 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | Q13547 | HDAC1 | Histone deacetylase 1 | Q06643 | LTB | Lymphotoxin-beta | 0.74 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.799 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
| Conivaptan | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Conivaptan | hsa04068 | FoxO signaling pathway | 3.80E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Conivaptan | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Conivaptan | hsa04071 | Sphingolipid signaling pathway | 4.31E-08 | 11 | P04049, P21453, Q9H228, P01375, Q13510, Q13362, Q9BX95, Q16539, P10415, Q9UQC2, P01042 | RAF1, S1PR1, EDG8, TNF, ASAH1, PPP2R5C, SGPP1, MAPK14, BCL2, GAB2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.934 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.841 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.777 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.787 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13510 | ASAH1 | Acid ceramidase | 0.748 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | -0.716 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.733 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.721 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.781 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | 0.7 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.708 | P06737 | PYGL | Glycogen phosphorylase, liver form | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.766 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.822 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.894 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | 0.708 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | -0.866 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P01042 | KNG1 | Kininogen-1 | -0.773 |
| Conivaptan | hsa04072 | Phospholipase D signaling pathway | 3.15E-03 | 9 | P04049, P42338, Q9UQC2, P43657, P25024, P25025, P19174, Q8WYR1, Q08828 | RAF1, PIK3CB, GAB2, P2RY5, CXCR1, CXCR2, PLCG1, PIK3R5, ADCY1 | More | | Conivaptan | hsa04080 | Neuroactive ligand-receptor interaction | 3.66E-06 | 12 | P08311, Q15722, P21453, Q9H228, O00398, P25116, P21462, P21730, Q16581, P07550, P01042, P35318 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, F2R, FPR1, C5AR1, C3AR1, ADRB2, KNG1, ADM | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P08311 | CTSG | Cathepsin G | -0.71 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08311 | CTSG | Cathepsin G | 0.829 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08311 | CTSG | Cathepsin G | -0.811 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | -0.832 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15722 | LTB4R | Leukotriene B4 receptor 1 | 0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q15722 | LTB4R | Leukotriene B4 receptor 1 | -0.891 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 1 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | 0.934 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.726 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | -0.841 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9H228 | EDG8 | Sphingosine 1-phosphate receptor 5 | 0.777 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | 0.768 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | -0.786 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00398 | P2RY10 | Putative P2Y purinoceptor 10 | 0.704 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P25116 | F2R | Proteinase-activated receptor 1 | -0.791 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.833 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.772 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 0.808 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | 1 | P21453 | S1PR1 | Sphingosine 1-phosphate receptor 1 | P07550 | ADRB2 | Beta-2 adrenergic receptor | 0.704 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P07550 | ADRB2 | Beta-2 adrenergic receptor | 0.735 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P01042 | KNG1 | Kininogen-1 | -0.773 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35318 | ADM | Pro-adrenomedullin [Cleaved into: Adrenomedullin | 0.727 |
| Conivaptan | hsa04110 | Cell cycle | 8.83E-05 | 8 | Q9UBD5, P06493, O60566, Q14683, P30304, P33981, P42773, P01106 | ORC3, CDK1, BUB1B, SMC1A, CDC25A, TTK, CDKN2C, MYC | More | | Conivaptan | hsa04114 | Oocyte meiosis | 4.41E-03 | 6 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0, P08069 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4, IGF1R | More | | Conivaptan | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Conivaptan | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Conivaptan | hsa04140 | Autophagy - animal | 2.40E-03 | 6 | P08069, P04049, P22694, Q14643, P10415, Q04759 | IGF1R, RAF1, PRKACB, ITPR1, BCL2, PRKCQ | More | | Conivaptan | hsa04141 | Protein processing in endoplasmic reticulum | 9.90E-07 | 16 | P18848, P30101, P07384, O95487, Q15437, P60604, Q99941, O75460, P11142, Q9H3Z4, P07900, P08238, Q9NR31, O95816, Q9H173, Q9UNL2 | ATF4, PDIA3, CAPN1, SEC24B, SEC23B, UBE2G2, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, HSP90AB1, SAR1A, BAG2, SIL1, SSR3 | More | | Conivaptan | hsa04142 | Lysosome | 6.04E-06 | 11 | P06865, P22304, P38571, Q13510, Q9UJJ9, P07602, Q9NRA2, P49279, P61916, Q04900, Q9Y227 | HEXA, IDS, LIPA, ASAH1, GNPTG, PSAP, SLC17A5, SLC11A1, NPC2, CD164, ENTPD4 | More | | Conivaptan | hsa04144 | Endocytosis | 3.18E-06 | 11 | P0DMV8, Q9H444, O75351, P62491, P42566, Q96B97, Q15438, Q8WU79, Q14161, Q9UMY4, Q9UNH7 | HSPA1A, CHMP4B, VPS4B, RAB11A, EPS15, SH3KBP1, PSCD1, SMAP1L, GIT2, SNX12, SNX6 | More | | Conivaptan | hsa04145 | Phagosome | 9.85E-07 | 13 | P11215, P60709, Q15075, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | ITGAM, ACTB, EEA1, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Conivaptan | hsa04150 | mTOR signaling pathway | 5.20E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Conivaptan | hsa04151 | PI3K-Akt signaling pathway | 6.51E-06 | 23 | P62753, P42338, P43657, O43521, P27348, P20827, P49767, Q13362, P07900, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P22105, P14784, P23458, Q99941, P18848, O00141, Q6ZUJ8, P30281 | RPS6, PIK3CB, P2RY5, BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AA1, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, TNXB, IL2RB, JAK1, CREBL1, ATF4, SGK, PIK3AP1, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.813 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | 0.784 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P42892 | ECE1 | Endothelin-converting enzyme 1 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.736 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P20827 | EFNA1 | Ephrin-A1 | -0.763 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q13362 | PPP2R5C | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.838 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O15335 | CHAD | Chondroadherin | -0.792 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.779 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.797 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.747 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Conivaptan | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Conivaptan | hsa04210 | Apoptosis | 4.72E-04 | 10 | Q13315, P10415, O76075, P01375, Q9NR28, P24522, Q16548, P43234, Q14643, P04049 | ATM, BCL2, DFFB, TNF, DIABLO, GADD45A, BCL2A1, CTSO, ITPR1, RAF1 | More | | Conivaptan | hsa04211 | Longevity regulating pathway | 5.33E-03 | 4 | P08069, P51828, Q99941, P18848 | IGF1R, ADCY7, CREBL1, ATF4 | More | | Conivaptan | hsa04213 | Longevity regulating pathway - multiple species | 5.94E-06 | 8 | P42338, P08069, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IGF1R, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Conivaptan | hsa04215 | Apoptosis - multiple species | 3.01E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Conivaptan | hsa04217 | Necroptosis | 1.70E-06 | 17 | P01375, P01568, P48023, Q13489, P98170, Q9NQC7, Q14765, P07900, P08238, P15104, P01584, Q6FI13, Q99878, Q9H444, O43633, P21796, Q08752 | TNF, IFNA21, FASLG, BIRC3, BIRC4, CYLD, STAT4, HSP90AA1, HSP90AB1, GLUL, IL1B, H2AC18; H2AC19, H2AC14, CHMP4B, CHMP2A, VDAC1, PPID | More | | Conivaptan | hsa04218 | Cellular senescence | 1.43E-04 | 3 | P31751, P04049, P0DP23 | AKT2, RAF1, CALM1 | More | | Conivaptan | hsa04260 | Cardiac muscle contraction | 4.02E-02 | 2 | P09493, P14927 | TPM1, UQCRB | More | | Conivaptan | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.15E-04 | 7 | P51828, P31751, Q99941, P18848, P0DP23, Q13557, P23634 | ADCY7, AKT2, CREBL1, ATF4, CALM1, CAMK2D, ATP2B4 | More | | Conivaptan | hsa04270 | Vascular smooth muscle contraction | 1.02E-07 | 9 | Q15746, P24844, P0DP23, P04049, Q08828, P51828, P35579, P35749, P35318 | MYLK, MYL9, CALM1, RAF1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Conivaptan | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Conivaptan | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Conivaptan | hsa04340 | Hedgehog signaling pathway | 3.19E-07 | 5 | P49841, P17612, P22694, Q13635, P10415 | GSK3B, PRKACA, PRKACB, PTCH1, BCL2 | More | | Conivaptan | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Conivaptan | hsa04360 | Axon guidance | 6.05E-05 | 9 | P16333, P20827, O95631, P42338, P07332, P23528, P04049, P19174, Q06124 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, RAF1, PLCG1, PTPN11 | More | | Conivaptan | hsa04370 | VEGF signaling pathway | 1.26E-04 | 5 | P16298, P31751, Q05397, Q02750, P04049 | PPP3CB, AKT2, PTK2, MAP2K1, RAF1 | More | | Conivaptan | hsa04371 | Apelin signaling pathway | 2.73E-09 | 13 | P62873, P63218, P50151, Q8WYR1, P31751, P04049, Q13370, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, AKT2, RAF1, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | -0.826 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14814 | MEF2D | Myocyte-specific enhancer factor 2D | 0.767 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.756 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q16566 | CAMK4 | Calcium/calmodulin-dependent protein kinase type IV | 0.708 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 |
| Conivaptan | hsa04380 | Osteoclast differentiation | 1.35E-05 | 13 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P31751, P01584, P14778, O75015, Q8WV28, P01375, Q15080, P78324 | CYLD, GAB2, MAPK14, JAK1, LCK, AKT2, IL1B, IL1R1, FCGR3B, BLNK, TNF, NCF4, SIRPA | More | | Conivaptan | hsa04390 | Hippo signaling pathway | 2.41E-03 | 4 | P63261, O15105, P04628, O43623 | ACTG1, SMAD7, WNT1, SNAI2 | More | | Conivaptan | hsa04392 | Hippo signaling pathway - multiple species | 3.01E-02 | 1 | Q6V0I7 | FAT4 | More | | Conivaptan | hsa04510 | Focal adhesion | 2.26E-04 | 9 | P16144, P08514, Q15746, P24844, Q15942, Q13489, P10415, P04049, P08069 | ITGB4, ITGA2B, MYLK, MYL9, ZYX, BIRC3, BCL2, RAF1, IGF1R | More | | Conivaptan | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Conivaptan | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Conivaptan | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | | Conivaptan | hsa04530 | Tight junction | 8.69E-07 | 9 | Q8TEU7, P63261, P16989, P56750, O00501, Q9Y478, Q92974, Q14247, P24844 | RAPGEF6, ACTG1, CSDA, CLDN17, CLDN5, PRKAB1, ARHGEF2, CTTN, MYL9 | More | | Conivaptan | hsa04540 | Gap junction | 1.73E-04 | 7 | P22694, Q13509, P68371, Q71U36, P04049, Q9NRA1, Q14643 | PRKACB, TUBB3, TUBB2C, TUBA1A, RAF1, PDGFC, ITPR1 | More | | Conivaptan | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.80E-04 | 5 | P04628, P40189, P04049, P08069, P14653 | WNT1, IL6ST, RAF1, IGF1R, HOXB1 | More | | Conivaptan | hsa04610 | Complement and coagulation cascades | 1.96E-08 | 5 | P25116, P01042, P0C0L4, P10909, Q16581 | F2R, KNG1, C4A, CLU, C3AR1 | More | | Conivaptan | hsa04611 | Platelet activation | 8.96E-08 | 8 | P25116, Q9Y490, P08514, Q15746, Q08828, Q8WYR1, P17612, P07359 | F2R, TLN1, ITGA2B, MYLK, ADCY1, PIK3R5, PRKACA, GP1BA | More | | Conivaptan | hsa04612 | Antigen processing and presentation | 5.83E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Conivaptan | hsa04613 | Neutrophil extracellular trap formation | 1.36E-06 | 21 | P04049, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, P0C0S5, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | RAF1, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, H2AFZ, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P06737 | PYGL | Glycogen phosphorylase, liver form | O60603 | TLR2 | Toll-like receptor 2 | 0.836 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60603 | TLR2 | Toll-like receptor 2 | -0.717 | P06737 | PYGL | Glycogen phosphorylase, liver form | P05164 | MPO | Myeloperoxidase | 0.858 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08246 | ELA2 | Neutrophil elastase | 0.817 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.813 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.813 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | -0.819 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P04908 | H2AC4; H2AC8 | Histone H2A type 1-B/E | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P0C0S5 | H2AFZ | Histone H2A.Z | 0.785 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.737 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.913 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.836 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.731 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20160 | AZU1 | Azurocidin | 0.781 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20160 | AZU1 | Azurocidin | -0.799 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08311 | CTSG | Cathepsin G | 0.829 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08311 | CTSG | Cathepsin G | 0.744 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08311 | CTSG | Cathepsin G | -0.811 | P06737 | PYGL | Glycogen phosphorylase, liver form | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.852 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.888 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.983 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | -0.772 | P06737 | PYGL | Glycogen phosphorylase, liver form | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.839 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O43315 | AQP9 | Aquaporin-9 | -0.764 | P06737 | PYGL | Glycogen phosphorylase, liver form | O43315 | AQP9 | Aquaporin-9 | 0.897 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O43315 | AQP9 | Aquaporin-9 | 0.934 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 |
| Conivaptan | hsa04614 | Renin-angiotensin system | 7.48E-03 | 4 | P50052, P15144, P08311, O75787 | AGTR2, ANPEP, CTSG, ATP6AP2 | More | | Conivaptan | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | | Conivaptan | hsa04621 | NOD-like receptor signaling pathway | 1.37E-05 | 18 | P01584, P07900, Q16539, Q14643, P23458, Q9H3M7, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | IL1B, HSP90AA1, MAPK14, ITPR1, JAK1, TXNIP, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Conivaptan | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | | Conivaptan | hsa04623 | Cytosolic DNA-sensing pathway | 3.64E-05 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | | Conivaptan | hsa04625 | C-type lectin receptor signaling pathway | 3.02E-05 | 12 | Q9ULY5, P04049, P01584, Q9NQC7, P20749, Q14643, P01375, Q13191, P31751, P0DP24, P0DP23, Q16539 | CLEC4E, RAF1, IL1B, CYLD, BCL3, ITPR1, TNF, CBLB, AKT2, CALM2, CALM1, MAPK14 | More | | Conivaptan | hsa04630 | JAK-STAT signaling pathway | 3.67E-03 | 4 | P48551, P40189, Q06124, P04049 | IFNAR2, IL6ST, PTPN11, RAF1 | More | | Conivaptan | hsa04640 | Hematopoietic cell lineage | 6.79E-04 | 16 | P13612, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375, P01584 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF, IL1B | More | | Conivaptan | hsa04650 | Natural killer cell mediated cytotoxicity | 3.12E-07 | 14 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, P04049, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, RAF1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P01375 | TNF | Tumor necrosis factor | P01375 | TNF | Tumor necrosis factor | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P01375 | TNF | Tumor necrosis factor | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.717 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.869 | P01375 | TNF | Tumor necrosis factor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.727 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P01375 | TNF | Tumor necrosis factor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.769 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.82 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.863 | P01375 | TNF | Tumor necrosis factor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.754 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.91 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.762 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P01375 | TNF | Tumor necrosis factor | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.838 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P01375 | TNF | Tumor necrosis factor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.814 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.846 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.853 | P01375 | TNF | Tumor necrosis factor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.814 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.853 |
| Conivaptan | hsa04657 | IL-17 signaling pathway | 1.85E-06 | 9 | P07900, O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.709 | P06737 | PYGL | Glycogen phosphorylase, liver form | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.924 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.932 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P06737 | PYGL | Glycogen phosphorylase, liver form | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.725 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09341 | CXCL1 | Growth-regulated alpha protein | 0.74 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P06737 | PYGL | Glycogen phosphorylase, liver form | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.917 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.778 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.775 | P06737 | PYGL | Glycogen phosphorylase, liver form | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 0.706 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P80188 | LCN2 | Neutrophil gelatinase-associated lipocalin | 0.715 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P08183 | ABCB1 | ATP-dependent translocase ABCB1 | P01375 | TNF | Tumor necrosis factor | -0.769 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | P01584 | IL1B | Interleukin-1 beta | 0.786 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 |
| Conivaptan | hsa04658 | Th1 and Th2 cell differentiation | 2.06E-09 | 15 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P42226, P23771, Q9UL17, P14784, P13765, P23458, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, STAT6, GATA3, TBX21, IL2RB, HLA-DOB, JAK1, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.736 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.777 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P06737 | PYGL | Glycogen phosphorylase, liver form | P42226 | STAT6 | Signal transducer and activator of transcription 6 | 0.852 | P06737 | PYGL | Glycogen phosphorylase, liver form | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.753 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.738 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.884 |
| Conivaptan | hsa04659 | Th17 cell differentiation | 3.19E-09 | 20 | P25963, Q04759, Q16539, P19174, P06239, P42224, P42226, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P01584, P08238, P07766, P09693, P20963, P23458 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, STAT6, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, IL1B, HSP90AB1, CD3E, CD3G, CD247, JAK1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P06737 | PYGL | Glycogen phosphorylase, liver form | P42226 | STAT6 | Signal transducer and activator of transcription 6 | 0.852 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P06737 | PYGL | Glycogen phosphorylase, liver form | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.845 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.738 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06737 | PYGL | Glycogen phosphorylase, liver form | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.753 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 |
| Conivaptan | hsa04660 | T cell receptor signaling pathway | 3.61E-08 | 17 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, P04049, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, RAF1, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06737 | PYGL | Glycogen phosphorylase, liver form | P01375 | TNF | Tumor necrosis factor | 0.759 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q04759 | PRKCQ | Protein kinase C theta type | -0.812 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P06737 | PYGL | Glycogen phosphorylase, liver form | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.852 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.8 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P06737 | PYGL | Glycogen phosphorylase, liver form | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06737 | PYGL | Glycogen phosphorylase, liver form | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06737 | PYGL | Glycogen phosphorylase, liver form | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.72 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q13547 | HDAC1 | Histone deacetylase 1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.806 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.863 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P06737 | PYGL | Glycogen phosphorylase, liver form | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.815 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 |
| Conivaptan | hsa04662 | B cell receptor signaling pathway | 1.49E-06 | 7 | P31751, P42338, P60033, P07948, P21854, Q8N149, P04049 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2, RAF1 | More | | Conivaptan | hsa04664 | Fc epsilon RI signaling pathway | 1.07E-08 | 9 | P31751, P04141, P42338, Q9UQC2, P07948, P19174, P04049, P09917, P20292 | AKT2, CSF2, PIK3CB, GAB2, LYN, PLCG1, RAF1, ALOX5, ALOX5AP | More | | Conivaptan | hsa04666 | Fc gamma R-mediated phagocytosis | 2.64E-02 | 6 | P04049, P23528, P06396, O14494, P14598, P17252 | RAF1, CFL1, GSN, PLPP1, NCF1, PRKCA | More | | Conivaptan | hsa04668 | TNF signaling pathway | 4.74E-02 | 3 | Q99941, P01584, O95429 | CREBL1, IL1B, BAG4 | More | | Conivaptan | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Conivaptan | hsa04710 | Circadian rhythm | 4.40E-02 | 1 | O15516 | CLOCK | More | | Conivaptan | hsa04713 | Circadian entrainment | 1.24E-04 | 5 | O15399, P0DP23, P62873, P63218, P50151 | GRIN2D, CALM1, GNB1, GNG5, GNG10 | More | | Conivaptan | hsa04714 | Thermogenesis | 1.95E-05 | 11 | Q16539, P15336, P51828, P63261, P62753, P33121, Q9Y478, P12074, O15239, Q16718, O14521 | MAPK14, ATF2, ADCY7, ACTG1, RPS6, ACSL1, PRKAB1, COX6A1, NDUFA1, NDUFA5, SDHD | More | | Conivaptan | hsa04720 | Long-term potentiation | 9.73E-04 | 7 | Q16566, P16298, P0DP23, P51812, O15399, Q02750, P04049 | CAMK4, PPP3CB, CALM1, RPS6KA3, GRIN2D, MAP2K1, RAF1 | More | | Conivaptan | hsa04722 | Neurotrophin signaling pathway | 7.07E-06 | 8 | Q05655, P31751, P04049, P49841, O43524, P48023, P52566, P0DP23 | PRKCD, AKT2, RAF1, GSK3B, FOXO3, FASLG, ARHGDIB, CALM1 | More | | Conivaptan | hsa04724 | Glutamatergic synapse | 5.79E-07 | 8 | P48058, O15399, P43003, P62873, P63218, P50151, P15104, Q9NSB8 | GRIA4, GRIN2D, SLC1A3, GNB1, GNG5, GNG10, GLUL, HOMER2 | More | | Conivaptan | hsa04725 | Cholinergic synapse | 6.68E-05 | 10 | P51828, P22694, Q14643, P62873, P63218, P50151, P18848, Q16566, Q13557, P10415 | ADCY7, PRKACB, ITPR1, GNB1, GNG5, GNG10, ATF4, CAMK4, CAMK2D, BCL2 | More | | Conivaptan | hsa04726 | Serotonergic synapse | 3.61E-04 | 5 | P62873, P63218, P50151, P09917, P04049 | GNB1, GNG5, GNG10, ALOX5, RAF1 | More | | Conivaptan | hsa04727 | GABAergic synapse | 2.50E-05 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Conivaptan | hsa04728 | Dopaminergic synapse | 1.96E-03 | 5 | P31751, Q99941, P18848, Q13557, P0DP23 | AKT2, CREBL1, ATF4, CAMK2D, CALM1 | More | | Conivaptan | hsa04730 | Long-term depression | 4.37E-03 | 4 | Q14344, P08069, P04049, P07948 | GNA13, IGF1R, RAF1, LYN | More | | Conivaptan | hsa04740 | Olfactory transduction | 2.41E-02 | 1 | P0DP23 | CALM1 | More | | Conivaptan | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Conivaptan | hsa04744 | Phototransduction | 1.60E-06 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Conivaptan | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.82E-06 | 14 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, P19174, P42338, Q14643, P24723, Q04759, P0DP24, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, PLCG1, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM2, CALM1 | More | | Conivaptan | hsa04810 | Regulation of actin cytoskeleton | 3.52E-04 | 5 | P24844, Q15746, P04049, P08514, P25116 | MYL9, MYLK, RAF1, ITGA2B, F2R | More | | Conivaptan | hsa04910 | Insulin signaling pathway | 2.43E-05 | 6 | P0DP23, P22694, P06737, P04049, P31751, P49841 | CALM1, PRKACB, PYGL, RAF1, AKT2, GSK3B | More | | Conivaptan | hsa04911 | Insulin secretion | 2.03E-05 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Conivaptan | hsa04912 | GnRH signaling pathway | 2.65E-05 | 12 | Q08828, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP24, P0DP23, P22694, P04049, P45985 | ADCY1, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM2, CALM1, PRKACB, RAF1, MAP2K4 | More | | Conivaptan | hsa04913 | Ovarian steroidogenesis | 8.54E-03 | 3 | P42330, P22694, P08069 | AKR1C3, PRKACB, IGF1R | More | | Conivaptan | hsa04914 | Progesterone-mediated oocyte maturation | 1.02E-03 | 6 | P08069, Q17RY0, Q9Y6D9, P51812, Q02750, P04049 | IGF1R, CPEB4, MAD1L1, RPS6KA3, MAP2K1, RAF1 | More | | Conivaptan | hsa04915 | Estrogen signaling pathway | 1.55E-09 | 11 | P04049, Q99941, P18848, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, Q15788 | RAF1, CREBL1, ATF4, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.756 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.824 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.704 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.714 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.786 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.753 | P42892 | ECE1 | Endothelin-converting enzyme 1 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.786 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DMV8 | HSPA1A | Heat shock 70 kDa protein 1A | 0.81 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | P0DP23 | CALM1 | Calmodulin-1 | 0.7 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.86 | P42892 | ECE1 | Endothelin-converting enzyme 1 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.819 | Q96RR4 | CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.723 |
| Conivaptan | hsa04916 | Melanogenesis | 4.92E-03 | 5 | P0DP23, Q9UJU2, P17252, P04628, P04049 | CALM1, LEF1, PRKCA, WNT1, RAF1 | More | | Conivaptan | hsa04917 | Prolactin signaling pathway | 3.49E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Conivaptan | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Conivaptan | hsa04919 | Thyroid hormone signaling pathway | 6.83E-04 | 5 | P49841, P04049, P22694, O60244, Q9NVC6 | GSK3B, RAF1, PRKACB, MED14, MED17 | More | | Conivaptan | hsa04920 | Adipocytokine signaling pathway | 3.41E-03 | 3 | Q06124, Q9Y478, P31751 | PTPN11, PRKAB1, AKT2 | More | | Conivaptan | hsa04921 | Oxytocin signaling pathway | 1.14E-04 | 6 | Q15746, Q08828, P04049, P24844, Q96RR4, Q8WYR1 | MYLK, ADCY1, RAF1, MYL9, CAMKK2, PIK3R5 | More | | Conivaptan | hsa04922 | Glucagon signaling pathway | 3.14E-03 | 6 | P22694, P06737, Q12778, P31751, P0DP23, Q14643 | PRKACB, PYGL, FOXO1, AKT2, CALM1, ITPR1 | More | | Conivaptan | hsa04923 | Regulation of lipolysis in adipocytes | 3.88E-03 | 4 | P07550, P42338, Q9Y4H2, P31751 | ADRB2, PIK3CB, IRS2, AKT2 | More | | Conivaptan | hsa04924 | Renin secretion | 2.62E-06 | 4 | P22694, P07550, Q14643, P0DP23 | PRKACB, ADRB2, ITPR1, CALM1 | More | | Conivaptan | hsa04925 | Aldosterone synthesis and secretion | 2.51E-05 | 5 | Q99941, P18848, P51828, Q13557, P23634 | CREBL1, ATF4, ADCY7, CAMK2D, ATP2B4 | More | | Conivaptan | hsa04926 | Relaxin signaling pathway | 7.01E-03 | 4 | Q99941, P18848, P51828, P04049 | CREBL1, ATF4, ADCY7, RAF1 | More | | Conivaptan | hsa04927 | Cortisol synthesis and secretion | 3.03E-04 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Conivaptan | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.61E-05 | 8 | Q14643, P51828, P22694, P23771, P04049, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, RAF1, CREBL1, ATF4, BCL2 | More | | Conivaptan | hsa04929 | GnRH secretion | 1.87E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Conivaptan | hsa04930 | Type II diabetes mellitus | 2.68E-02 | 1 | Q05655 | PRKCD | More | | Conivaptan | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Conivaptan | hsa04932 | Non-alcoholic fatty liver disease | 9.03E-06 | 12 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, O15239, Q16718, O95298, O14521 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFA5, NDUFC2, SDHD | More | | Conivaptan | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Conivaptan | hsa04934 | Cushing syndrome | 2.54E-06 | 8 | Q14643, Q99941, P18848, P51828, P22694, O15169, Q13557, P04628 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB, AXIN1, CAMK2D, WNT1 | More | | Conivaptan | hsa04935 | Growth hormone synthesis, secretion and action | 5.33E-03 | 4 | P51828, P04049, Q99941, P18848 | ADCY7, RAF1, CREBL1, ATF4 | More | | Conivaptan | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Conivaptan | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.40E-02 | 1 | O00141 | SGK | More | | Conivaptan | hsa04962 | Vasopressin-regulated water reabsorption | 2.95E-04 | 3 | P52566, P62491, P46459 | ARHGDIB, RAB11A, NSF | More | | Conivaptan | hsa04964 | Proximal tubule bicarbonate reclamation | 2.17E-03 | 1 | P00918 | CA2 | More | | Conivaptan | hsa04966 | Collecting duct acid secretion | 2.17E-03 | 1 | P00918 | CA2 | More | | Conivaptan | hsa04970 | Salivary secretion | 3.24E-06 | 7 | P07550, Q08828, P51828, P22694, Q14643, P0DP24, P0DP23 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, CALM2, CALM1 | More | | Conivaptan | hsa04971 | Gastric acid secretion | 2.57E-03 | 4 | P51828, P15311, P0DP23, Q13557 | ADCY7, VIL2, CALM1, CAMK2D | More | | Conivaptan | hsa04972 | Pancreatic secretion | 4.73E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Conivaptan | hsa04973 | Carbohydrate digestion and absorption | 4.61E-03 | 3 | O43451, P42338, P31751 | MGAM, PIK3CB, AKT2 | More | | Conivaptan | hsa04976 | Bile secretion | 1.90E-04 | 6 | O43315, Q08828, P51828, P22694, P08183, Q14032 | AQP9, ADCY1, ADCY7, PRKACB, ABCB1, BAAT | More | | Conivaptan | hsa05010 | Alzheimer disease | 7.84E-04 | 10 | Q92542, P05496, P12074, Q00535, O75460, P0DP23, P01584, O15169, P31751, P45880 | NCSTN, ATP5G1, COX6A1, CDK5, ERN1, CALM1, IL1B, AXIN1, AKT2, VDAC2 | More | | Conivaptan | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | | Conivaptan | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Conivaptan | hsa05020 | Prion disease | 1.37E-03 | 11 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, P45880, P49841, Q99941, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, VDAC2, GSK3B, CREBL1, MAPK14 | More | | Conivaptan | hsa05022 | Pathways of neurodegeneration - multiple diseases | 8.04E-04 | 10 | P49841, Q16718, O14521, Q06055, Q13561, Q16539, Q00535, Q08752, O15020, P0DP23 | GSK3B, NDUFA5, SDHD, ATP5G2, DCTN2, MAPK14, CDK5, PPID, SPTBN2, CALM1 | More | | Conivaptan | hsa05030 | Cocaine addiction | 6.96E-03 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Conivaptan | hsa05031 | Amphetamine addiction | 9.24E-04 | 4 | P0DP23, Q13557, Q99941, P18848 | CALM1, CAMK2D, CREBL1, ATF4 | More | | Conivaptan | hsa05032 | Morphine addiction | 7.62E-04 | 5 | P62873, P63218, P50151, Q13370, P43250 | GNB1, GNG5, GNG10, PDE3B, GRK6 | More | | Conivaptan | hsa05034 | Alcoholism | 4.32E-07 | 14 | O15399, Q16566, P0DP23, Q96RR4, P62873, P63218, P50151, P04049, Q93077, P62807, Q93079, O60814, P84243, P68431 | GRIN2D, CAMK4, CALM1, CAMKK2, GNB1, GNG5, GNG10, RAF1, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Conivaptan | hsa05100 | Bacterial invasion of epithelial cells | 4.54E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | | Conivaptan | hsa05110 | Vibrio cholerae infection | 5.58E-05 | 6 | Q13488, Q99437, P17252, P19174, P17612, P60709 | TCIRG1, ATP6V0B, PRKCA, PLCG1, PRKACA, ACTB | More | | Conivaptan | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 5.83E-07 | 9 | Q16539, P25963, Q13488, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, NFKBIA, TCIRG1, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Conivaptan | hsa05130 | Pathogenic Escherichia coli infection | 1.35E-04 | 13 | Q71U36, Q14247, O00501, P16333, Q92974, Q13509, P68371, P63261, P25116, Q14344, P25963, Q06124, O95487 | TUBA1A, CTTN, CLDN5, NCK1, ARHGEF2, TUBB3, TUBB2C, ACTG1, F2R, GNA13, NFKBIA, PTPN11, SEC24B | More | | Conivaptan | hsa05131 | Shigellosis | 4.50E-03 | 8 | Q05655, Q9NQL2, P0CG47, Q14141, Q96JJ3, Q05397, Q13315, P07737 | PRKCD, RRAGD, UBB, SEPT6, ELMO2, PTK2, ATM, PFN1 | More | | Conivaptan | hsa05132 | Salmonella infection | 1.71E-03 | 17 | P51617, P25963, P08238, P04049, Q9UJU2, P84095, Q13489, P10415, O75369, P07737, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, RAF1, LEF1, RHOG, BIRC3, BCL2, FLNB, PFN1, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Conivaptan | hsa05133 | Pertussis | 3.02E-03 | 1 | P0C0L4 | C4A | More | | Conivaptan | hsa05134 | Legionellosis | 1.05E-04 | 8 | P01584, P25963, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, NFKBIA, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Conivaptan | hsa05140 | Leishmaniasis | 5.36E-06 | 15 | P13612, O75015, P14598, P11215, P23458, P42224, P13765, O60603, P25963, P01375, P01584, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, JAK1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, IL1B, PTPN6, MARCKSL1, MAPK14, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.814 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.818 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.785 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P11215 | ITGAM | Integrin alpha-M | -0.78 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.81 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.754 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.841 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49006 | MARCKSL1 | MARCKS-related protein | -0.852 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.708 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.752 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.719 |
| Conivaptan | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Conivaptan | hsa05144 | Malaria | 3.31E-04 | 8 | P60033, P69905, P68871, O60603, P01375, P35443, P01584, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, IL1B, KLRK1 | More | | Conivaptan | hsa05145 | Toxoplasmosis | 2.50E-04 | 7 | Q16539, P10415, Q13489, P23458, P13765, Q8WYR1, P0DMV8 | MAPK14, BCL2, BIRC3, JAK1, HLA-DOB, PIK3R5, HSPA1A | More | | Conivaptan | hsa05146 | Amoebiasis | 2.17E-05 | 13 | P01584, P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | IL1B, CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Conivaptan | hsa05150 | Staphylococcus aureus infection | 4.01E-05 | 11 | P0C0L4, P21730, P21462, O75015, P13765, Q16581, P13646, P59665, P59666, P12838, P49913 | C4A, C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, KRT13, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Conivaptan | hsa05152 | Tuberculosis | 1.89E-04 | 12 | P04049, Q13488, P0DP23, P48382, O60603, P31751, P10415, P13765, P01568, Q9UDY8, Q16539, P51617 | RAF1, TCIRG1, CALM1, RFX5, TLR2, AKT2, BCL2, HLA-DOB, IFNA21, MALT1, MAPK14, IRAK1 | More | | Conivaptan | hsa05160 | Hepatitis C | 1.40E-03 | 5 | P60033, P04049, P49841, P01375, P48023 | CD81, RAF1, GSK3B, TNF, FASLG | More | | Conivaptan | hsa05161 | Hepatitis B | 5.33E-03 | 4 | P04049, Q99941, P18848, P27348 | RAF1, CREBL1, ATF4, YWHAQ | More | | Conivaptan | hsa05162 | Measles | 2.84E-03 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Conivaptan | hsa05163 | Human cytomegalovirus infection | 1.51E-06 | 23 | P31751, P04049, P25963, P62873, P63218, P50151, Q14643, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P04637, O00463, P30101, P01568 | AKT2, RAF1, NFKBIA, GNB1, GNG5, GNG10, ITPR1, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, TP53, TRAF5, PDIA3, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.756 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.83 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | -0.825 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P01568 | IFNA21 | Interferon alpha-21 | -0.733 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 |
| Conivaptan | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | | Conivaptan | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.27E-07 | 12 | P01568, P31751, P42224, P25963, P62873, P63218, P50151, P19174, P04049, P07948, P04141, P0DP23 | IFNA21, AKT2, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, RAF1, LYN, CSF2, CALM1 | More | | Conivaptan | hsa05168 | Herpes simplex virus 1 infection | 5.00E-03 | 12 | P25963, P01568, P42224, Q07955, Q01130, P84103, Q13243, Q13489, P30101, Q13398, O75820, Q9NZL3 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS3, SFRS5, BIRC3, PDIA3, ZNF211, ZNF189, ZNF224 | More | | Conivaptan | hsa05169 | Epstein-Barr virus infection | 4.32E-02 | 11 | P13765, O00463, P16070, P10415, Q16539, P24522, Q8WV28, P01375, O60603, P09693, P20963 | HLA-DOB, TRAF5, CD44, BCL2, MAPK14, GADD45A, BLNK, TNF, TLR2, CD3G, CD247 | More | | Conivaptan | hsa05170 | Human immunodeficiency virus 1 infection | 4.58E-08 | 24 | P31751, P04049, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, Q05397, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, P19174, P23528, P10415, Q93034, Q9Y6Q5 | AKT2, RAF1, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, PLCG1, CFL1, BCL2, CUL5, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.96 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.932 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.83 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | -0.825 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P01568 | IFNA21 | Interferon alpha-21 | -0.733 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P23528 | CFL1 | Cofilin-1 | 0.738 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 |
| Conivaptan | hsa05171 | Coronavirus disease - COVID-19 | 3.18E-03 | 7 | P01584, P62753, P36578, P62888, P61927, P61513, P62829 | IL1B, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23 | More | | Conivaptan | hsa05200 | Pathways in cancer | 2.93E-08 | 28 | Q13751, P42338, P08238, P42224, P25963, P19174, P43246, P84022, Q13485, P20585, Q13547, P30281, Q13489, P98170, P49767, P31751, P43657, P62873, P63218, P50151, Q14344, Q7LDG7, P78417, O75293, P0DP23, P01568, P14784, P01042 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, SMAD4, MSH3, HDAC1, CCND3, BIRC3, BIRC4, VEGFC, AKT2, P2RY5, GNB1, GNG5, GNG10, GNA13, RASGRP2, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.816 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P20585 | MSH3 | DNA mismatch repair protein Msh3 | 0.825 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.756 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P01568 | IFNA21 | Interferon alpha-21 | -0.733 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
| Conivaptan | hsa05202 | Transcriptional misregulation in cancer | 6.18E-09 | 24 | Q12778, Q15532, Q13315, P17844, P14780, P27930, P14923, Q16548, Q13489, Q13077, Q15652, O15550, P08069, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P68431, Q13547, Q92769, P12980, P24522 | FOXO1, SS18, ATM, DDX5, MMP9, IL1R2, JUP, BCL2A1, BIRC3, TRAF1, JMJD1C, UTX, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.795 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15532 | SS18 | Protein SSXT | -0.772 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q15532 | SS18 | Protein SSXT | -0.829 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.863 | P06737 | PYGL | Glycogen phosphorylase, liver form | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.917 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.746 | P06737 | PYGL | Glycogen phosphorylase, liver form | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.881 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.967 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.751 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.832 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.783 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q15652 | JMJD1C | Probable JmjC domain-containing histone demethylation protein 2C | 0.754 | P06737 | PYGL | Glycogen phosphorylase, liver form | O15550 | UTX | Lysine-specific demethylase 6A | 0.724 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | O15550 | UTX | Lysine-specific demethylase 6A | 0.73 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O15550 | UTX | Lysine-specific demethylase 6A | -0.778 | P08069 | IGF1R | Insulin-like growth factor 1 receptor | P08069 | IGF1R | Insulin-like growth factor 1 receptor | 1 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P06737 | PYGL | Glycogen phosphorylase, liver form | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.73 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P06737 | PYGL | Glycogen phosphorylase, liver form | P05164 | MPO | Myeloperoxidase | 0.858 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P05164 | MPO | Myeloperoxidase | 0.711 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P05164 | MPO | Myeloperoxidase | -0.866 | P06737 | PYGL | Glycogen phosphorylase, liver form | P12838 | DEFA4 | Neutrophil defensin 4 | 0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.784 | P06737 | PYGL | Glycogen phosphorylase, liver form | P08246 | ELA2 | Neutrophil elastase | 0.817 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P08246 | ELA2 | Neutrophil elastase | -0.76 | P06737 | PYGL | Glycogen phosphorylase, liver form | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.742 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.879 | P06737 | PYGL | Glycogen phosphorylase, liver form | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.847 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.919 | Q16581 | C3AR1 | C3a anaphylatoxin chemotactic receptor | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | -0.79 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12980 | LYL1 | Protein lyl-1 | 0.784 | P06737 | PYGL | Glycogen phosphorylase, liver form | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.822 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 |
| Conivaptan | hsa05203 | Viral carcinogenesis | 2.63E-03 | 7 | Q99941, P18848, P27348, Q15283, P61978, P62807, O60814 | CREBL1, ATF4, YWHAQ, RASA2, HNRPK, HIST1H2BC, H2BC12 | More | | Conivaptan | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Conivaptan | hsa05205 | Proteoglycans in cancer | 1.89E-03 | 12 | Q13009, Q12955, Q14643, O75369, P04049, P14780, P17252, O60603, P08069, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, RAF1, MMP9, PRKCA, TLR2, IGF1R, WNT1, PTCH1, CD63 | More | | Conivaptan | hsa05206 | MicroRNAs in cancer | 6.19E-04 | 7 | P15311, P21860, P61978, P46531, P63279, P22105, P04049 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RAF1 | More | | Conivaptan | hsa05210 | Colorectal cancer | 7.91E-03 | 5 | P84022, Q13485, P43246, P04049, O75293 | SMAD3, SMAD4, MSH2, RAF1, GADD45B | More | | Conivaptan | hsa05211 | Renal cell carcinoma | 1.99E-04 | 4 | Q06124, Q99814, P31751, P04049 | PTPN11, EPAS1, AKT2, RAF1 | More | | Conivaptan | hsa05212 | Pancreatic cancer | 6.80E-06 | 8 | P42338, P31751, P04049, P42224, P37173, P84022, Q13485, O75293 | PIK3CB, AKT2, RAF1, STAT1, TGFBR2, SMAD3, SMAD4, GADD45B | More | | Conivaptan | hsa05213 | Endometrial cancer | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Conivaptan | hsa05214 | Glioma | 2.06E-06 | 7 | P08069, P0DP23, Q16566, P04049, P31751, P19174, O75293 | IGF1R, CALM1, CAMK4, RAF1, AKT2, PLCG1, GADD45B | More | | Conivaptan | hsa05215 | Prostate cancer | 1.65E-04 | 2 | P08069, P04049 | IGF1R, RAF1 | More | | Conivaptan | hsa05217 | Basal cell carcinoma | 1.30E-03 | 4 | Q13635, P49841, Q9UJU2, P24522 | PTCH1, GSK3B, LEF1, GADD45A | More | | Conivaptan | hsa05218 | Melanoma | 5.24E-06 | 3 | P08069, P31751, P04049 | IGF1R, AKT2, RAF1 | More | | Conivaptan | hsa05219 | Bladder cancer | 5.65E-03 | 3 | P14780, P04637, P04049 | MMP9, TP53, RAF1 | More | | Conivaptan | hsa05220 | Chronic myeloid leukemia | 4.90E-04 | 7 | Q13547, Q13485, P84022, P31751, P42338, P04049, O75293 | HDAC1, SMAD4, SMAD3, AKT2, PIK3CB, RAF1, GADD45B | More | | Conivaptan | hsa05221 | Acute myeloid leukemia | 8.16E-04 | 2 | P31751, P04049 | AKT2, RAF1 | More | | Conivaptan | hsa05222 | Small cell lung cancer | 4.77E-03 | 5 | P31751, Q13751, Q13489, P98170, O75293 | AKT2, LAMB3, BIRC3, BIRC4, GADD45B | More | | Conivaptan | hsa05223 | Non-small cell lung cancer | 3.07E-04 | 6 | P17252, O43524, P31751, P19174, P04049, O75293 | PRKCA, FOXO3, AKT2, PLCG1, RAF1, GADD45B | More | | Conivaptan | hsa05224 | Breast cancer | 2.75E-03 | 6 | P04049, P08069, P49841, Q92837, P04637, P24522 | RAF1, IGF1R, GSK3B, FRAT1, TP53, GADD45A | More | | Conivaptan | hsa05225 | Hepatocellular carcinoma | 1.65E-04 | 2 | P04049, P08069 | RAF1, IGF1R | More | | Conivaptan | hsa05226 | Gastric cancer | 6.81E-04 | 2 | P04049, P31751 | RAF1, AKT2 | More | | Conivaptan | hsa05230 | Central carbon metabolism in cancer | 1.12E-03 | 2 | P04049, P31751 | RAF1, AKT2 | More | | Conivaptan | hsa05231 | Choline metabolism in cancer | 8.00E-04 | 7 | P04049, Q9Y259, P19174, P23743, P49619, O14494, P17252 | RAF1, CHKB, PLCG1, DGKA, DGKG, PLPP1, PRKCA | More | | Conivaptan | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 5.08E-06 | 14 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, P04049, P23458, O60603, P10747, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, RAF1, JAK1, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Conivaptan | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Conivaptan | hsa05321 | Inflammatory bowel disease | 2.20E-07 | 8 | O60603, P01375, P13765, Q14765, Q9UL17, P42226, P23771, P01584 | TLR2, TNF, HLA-DOB, STAT4, TBX21, STAT6, GATA3, IL1B | More | | Conivaptan | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Conivaptan | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Conivaptan | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Conivaptan | hsa05332 | Graft-versus-host disease | 3.29E-04 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Conivaptan | hsa05410 | Hypertrophic cardiomyopathy | 1.73E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Conivaptan | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 2.97E-05 | 3 | P54284, P15924, P26012 | CACNB3, DSP, ITGB8 | More | | Conivaptan | hsa05414 | Dilated cardiomyopathy | 4.55E-02 | 2 | P54284, P26678 | CACNB3, PLN | More | | Conivaptan | hsa05415 | Diabetic cardiomyopathy | 2.61E-04 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | Conivaptan | hsa05416 | Viral myocarditis | 2.30E-02 | 2 | P10747, P63261 | CD28, ACTG1 | More | | Conivaptan | hsa05418 | Fluid shear stress and atherosclerosis | 2.84E-03 | 8 | Q16539, P31751, P10599, P14780, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, TXN, MMP9, TP53, IL1R1, IL1R2, CALM1 | More | | |